Investors
Creating Opportunity in Point-of-Care Diagnostics
NanoDx™, Inc. is a privately held medical device company developing innovative, point-of-care, in-vitro diagnostic solutions targeting unmet clinical needs worldwide. The company’s proprietary platform is a first-of-its kind device employing nanowire biosensor technology to deliver accurate test results at the patient’s side in just minutes.
![istockphoto-1434116614-2048x2048](https://nanodiagnostics.com/wp-content/uploads/2023/11/istockphoto-1434116614-2048x2048-1.png)